Jiangsu Senxuan Pharmaceutical and Chemical

Jiangsu Senxuan Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals. The company is a major global supplier of key products such as gabapentin, pregabalin, and flurbiprofen, serving the neurology and pain management markets. Additionally, Senxuan produces critical intermediates for antiviral medications, including those used in ritonavir and lopinavir formulations. Operating multiple large-scale manufacturing facilities in Jiangsu province, the company provides CDMO services to global pharmaceutical partners. Senxuan is publicly listed on the Beijing Stock Exchange and is recognized for its expertise in complex chemical synthesis and process optimization.